{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:16:30Z","timestamp":1792631790637,"version":"4.5.0"},"reference-count":11,"publisher":"Royal College of Psychiatrists","issue":"2","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["BJPsych Int."],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>The South Asian region, including India, faces an increased prevalence of illicit drug use. Key challenges include rising opioid use, injecting drug use and spread of stimulant use from some pockets to other regions of the country. Challenges faced are poor surveillance, lack of evidence-based and structured prevention programmes, wide treatment gaps and inadequate social capital for reintegration of substance users into society. The drug control efforts in India have resulted in an improved drug offence surveillance system, increased community awareness, a growing network of drug treatment centres and resource-building measures. India has made pioneering efforts in the field of harm reduction in the South Asian region. The steps taken have the potential of applicability across other South Asian, as well as most low- and middle-income, countries around the world.<\/jats:p>","DOI":"10.1192\/bji.2025.3","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T01:34:11Z","timestamp":1741570451000},"page":"55-58","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["Drug control: initiatives from India"],"prefix":"10.1192","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8547-375X","authenticated-orcid":false,"given":"Shalini","family":"Singh","sequence":"first","affiliation":[{"name":"All India Institute of Medical Sciences (AIIMS)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-5968","authenticated-orcid":false,"given":"Rakesh","family":"Chadda","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences (AIIMS)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"S2056474025000030_ref7","unstructured":"7 United Nations Office on Drugs and Crime. India: UNODC strengthens Indian law enforcement responses to address the drug problem with capacity building and knowledge sharing. UNODC, 2023 (https:\/\/www.unodc.org\/southasia\/\/frontpage\/2023\/June\/india_-unodc-strengthens-indian-law-enforcement-responses-to-address-the-drug-problem-with-capacity-building-and-knowledge-sharing.html [cited 27 May 2024])."},{"key":"S2056474025000030_ref8","unstructured":"8 Society for Promotion of Youth and Masses. NAVCHETNA: a new consciousness on life skills and drug education for school children. SPYM, 2023 (https:\/\/spym.org\/publications-reports\/ [cited 27 May 2024])."},{"key":"S2056474025000030_ref9","unstructured":"9 Ministry of Social Justice and Empowerment - Government of India. National Action Plan for Drug Demand Reduction. Ministry of Social Justice and Empowerment, 2024 (https:\/\/socialjustice.gov.in\/schemes\/42 [cited 23 May 2024])."},{"key":"S2056474025000030_ref5","volume-title":"Detection of New Psychoactive Substances among Substance Abuse Treatment Seekers in India-Multi-Centric Study","author":"Chadda","year":"2023"},{"key":"S2056474025000030_ref10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4103\/psychiatry.IndianJPsychiatry_19_17","article-title":"Treatment of substance use disorders through the government health facilities: developments in the \u201cdrug de-addiction programme\u201d of Ministry of Health and Family Welfare, Government of India","volume":"59","author":"Dhawan","year":"2017","journal-title":"Indian J Psychiatry"},{"key":"S2056474025000030_ref11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/psychiatry.IndianJPsychiatry_43_19","article-title":"School-based substance use disorder prevention in India: a brief appraisal","volume":"62","author":"Pattojoshi","year":"2020","journal-title":"Indian J of Psychiatry"},{"key":"S2056474025000030_ref2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4103\/0019-5545.196701","article-title":"Injection drug use among children and adolescents in India: ringing the alarm bells","volume":"58","author":"Dhawan","year":"2016","journal-title":"Indian J Psychiatry"},{"key":"S2056474025000030_ref1","volume-title":"Magnitude of Substance Abuse in India 2019: Executive Summary","author":"Ambekar","year":"2019"},{"key":"S2056474025000030_ref3","unstructured":"3 United Nations Office on Drugs and Crime. India: Amphetamine-type stimulants now an emerging trend in the country. UNODC, 2014 (https:\/\/www.unodc.org\/southasia\/frontpage\/2014\/Jan\/india-first-ever-study-looks-at-trends-in-amphetamine-type-stimulants-use.html [cited 23 May 2024])."},{"key":"S2056474025000030_ref6","unstructured":"6 United Nations Office on Drugs and Crime. India: UNODC collaborates with Government of India's ITEC mechanism to strengthen drug law enforcement in South-South capacity building. UNODC, 2023 (https:\/\/www.unodc.org\/southasia\/\/frontpage\/2023\/July\/india_-unodc-collaborates-with-government-of-indias-itec-mechanism-to-strengthen-drug-law-enforcement-in-south-south-capacity-building.html [cited 27 May 2024])."},{"key":"S2056474025000030_ref4","unstructured":"4 United Nations Office on Drugs and Crime. World Drug Report 2023 \u2013 Special Points of Interests. UNODC, 2023 (https:\/\/www.unodc.org\/res\/WDR-2023\/Special_Points_WDR2023_web_DP.pdf)."}],"container-title":["BJPsych International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2056474025000030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:29:01Z","timestamp":1761910141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2056474025000030\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2056474025000030"],"URL":"https:\/\/doi.org\/10.1192\/bji.2025.3","relation":{},"ISSN":["2056-4740","2058-6264"],"issn-type":[{"value":"2056-4740","type":"print"},{"value":"2058-6264","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}